Ross Todd is the Editor/columnist for the Am Law Litigation Daily. He writes about litigation of all sorts. Previously, Ross was the Bureau Chief of The Recorder, ALM's California affiliate. Contact Ross at [email protected]. On Twitter: @Ross_Todd.
September 02, 2021 | Litigation Daily
'Build, Build, Build': What Other Firms Can Take Away from Cadwalader's Rapid Integration of Nick Gravante and His TeamGravante and partners Philip Iovieno, Karen Dyer and Lawrence Brandman joined Cadwalader from Boies Schiller and brought all their clients with them.
By Ross Todd
6 minute read
September 01, 2021 | Litigation Daily
No Peek Behind the Curtain: Requests for Litigation Funding Docs Largely Go UnheededA comprehensive survey of 52 cases where judges have considered whether to force parties to hand over their communications with litigation funders finds the "vast majority" deny such requisitions because of the work-product doctrine.
By Ross Todd
5 minute read
August 31, 2021 | Litigation Daily
Is This a Thing? Dozens of New Suits Target Magazine Publishers Under Michigan Privacy LawPlaintiffs have fired off more than a dozen lawsuits in the Eastern District of Michigan this month claiming magazine publishers violated a state privacy law carrying statutory damages of $5,000 a pop.
By Ross Todd
7 minute read
August 30, 2021 | Litigation Daily
These New SPAC Suits Really Have Your Firm's Attention, Don't They?A group of 49 law firms came together late last week to issue a statement saying the central claim of the derivative suits targeting certain special purpose acquisition companies are "without factual or legal basis."
By Ross Todd
4 minute read
August 27, 2021 | Litigation Daily
Litigators of the Week: This Covington Trial Team Protected AbbVie's $8B Per Year Cancer Treatment From a Generic ChallengeFollowing a seven-day remote bench trial last year, Christopher Sipes, Erica Andersen, and Brianne Bharkhda of Covington & Burling got a ruling from a federal judge in Delaware this week finding the four patents covering cancer treatment Imbruvica were valid and infringed.
By Ross Todd
10 minute read
August 27, 2021 | Litigation Daily
Litigator of the Week Runners-Up and Shout OutsLast month we gave a Gibson, Dunn & Crutcher team runners-up honors for fending off a preliminary injunction in a high-profile trade secret spat. Welp, it's only fair that we give their opposing counsel at Quinn Emanuel Urquhart & Sullivan a runners-up nod for getting a ruling this week denying a motion to dismiss in the case.
By Ross Todd
5 minute read
August 26, 2021 | Litigation Daily
How Were the Soccer Federations at the Center of a Global Corruption Scandal Found to Be Its Victims? It's a $201M QuestionSidley Austin's Timothy Treanor, who represented Concacaf, one of the three international organizations at the center of the case, says that he and his colleagues found evidence that corrupt officials had victimized the organization.
By Ross Todd
9 minute read
August 25, 2021 | Litigation Daily
5 Tips for Effective, Targeted Cross-ExaminationsZol Rainey, a senior litigation counsel at the Consumer Financial Protection Bureau, says to think of each cross-examination as a piece of a larger trial puzzle. "Don't try to hit a home run or win your entire case with just one cross-examination," he says.
By Ross Todd
5 minute read
August 24, 2021 | Litigation Daily
A Litigator's Primer for Blockchain and CryptoWhen is a crypto asset a security? Stick around long enough and you just might find out.
By Ross Todd
5 minute read
August 23, 2021 | Litigation Daily
Litigation Leaders: Munger Tolles Chair Brad Brian on the Virtues of the Firm's 1-1 Partner-to-Associate Ratio"Since our firm's inception in 1962, our strategy has remained the same: We take on the toughest cases, hire the brightest lawyers, and do it in a democratic environment where, from day one, lawyers are given early responsibility and treated like owners."
By Ross Todd
17 minute read
Trending Stories